Objective
Neuromuscular diseases (NMD) such as Dystrophies, Atrophies, Paralysis or Neuropathies are a group of more than 150 genetic illnesses affecting the lower neuromotor system, which include the muscles and nerves system. NMDs share the common traits of childhood onset and progressive muscle weakness, which lead to walk disability, loss of autonomy and psychosocial consequences.
There is currently not treatment available to halt the progressive course of these NMDs. Most therapeutic approaches are limited to medicines (by reducing symptoms) and musculoskeletal rehabilitation in-clinic programs, as neurological disorders main feature is the loss of muscles strength and a progressive lack of walking. The key is maintaining walking ability for slowing the deterioration caused by permanent sitting, giving hope for a better and more independent life. Marsi Bionics offers an innovative approach: Wearable Gait Exoskeletons as and effective 24/7 in-house therapy solution for allowing NMD children to walk.
ATLAS 2020 is the first paediatric exoskeleton we developed for using in hospitals/rehabilitation centres. Our purpose and why we need and expert in biomechanics is to get ready a more advanced version, ATLAS 2030 for expanding rehabilitation to home and activities of daily living, building a paradigm for NMD rehabilitation. To achieve this goal we are working on providing self-balance capabilities to the exoskeleton. The company is looking for a qualified biomechanical engineer with an excellent background in human locomotion for improving ergonomics and biomechanics of gait balance of our bionics exoskeletons and to analyse the gait dysfunctions from NMD pathologies.
The potential Marsi Bionics would achieve improving ATLAS 2030, by accomplishing the ideal ergonomics aspects related to each NMD mobility pattern during the gait by recruiting an expert in Biomechanics, will reinforce research in robotic area for health and will create new market opportunities.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine physiotherapy
- medical and health sciences basic medicine neurology muscular dystrophies duchenne muscular dystrophy
- medical and health sciences basic medicine pathology
- natural sciences biological sciences biophysics
- social sciences psychology ergonomics
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.2.2. - Enhancing the innovation capacity of SMEs
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
CSA - Coordination and support action
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-INNOSUP-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
28521 RIVAS VACIAMADRID
Spain
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.